</span><b><span style="font-family:Verdana;">Purpose</span></b></span></span><span style="font-family:Verdana;"><span style="font-family:Verd...</span><b><span style="font-family:Verdana;">Purpose</span></b></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><b><span style="font-family:Verdana;">:</span></b></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"></b></span></span></span><span><span><span style="font-family:""> </span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">The purpose of this article is </span></span></span><span><span><span style="font-family:""><span style="font-family:Verdana;">to investigate the clinical value of TB-IGRA</span><span style="font-family:Verdana;"> (Tuberculosis-Interferon </span><span style="font-family:Verdana;">Gamma Release Assay), PPD (Intradermal </span><span style="font-family:Verdana;">Terbuculin Test), TB-DNA-PCR (Tuberculosis-Deoxyribonucleic-Polymerase</span><span style="font-family:Verdana;"> Chain Reaction) and TB-Ab (Tuberculosis-Antibody) in diagnosing silicosis complicated with pulmonary tuberculosis. <b></span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><b><span style="font-family:Verdana;">Methods</span></b></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><b><span style="font-family:Verdana;">:</span></b></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"></b></span></span></span><span><span><b><span style="font-family:""> </span></b></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">53 cases of suspected silicosis complicated with pulmonary tuberculosis were selected in the time span ranging from February 2017 to May 2019. TB-IGRA test, PPD test, TB-DNA-PCR and TB-Ab detection were performed. The sensitivity, specificity, positive predictive value and negative predictive value were calculated. </span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><b></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><b><span style="font-family:Verdana;">Results</span></b></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><b><span style="font-family:Verdana;">:</span></b></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"></b></span></span></span><span><span><span style="font-family:""> </span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">Silicosis and pulmonary tuberculosis were diagnosed in 11 cases, with an incidence of 20.75%. The positive rates of TB-IGRA, PPD, TB-DNA-PCR and TB-Ab were 66.04%, 30.19%, 5.67% and 26.42%, respectively. The sensitivity was 90.91%, 81.82%, 27.27% and 54.55% respectively. The specificity was 42.86%, 80.95%, 100% and 80.95% respectively. The positive predictive values were 28.57%, 50%, 100% and 42.86% respectively. The negative predictive values were 94.44%, 91.89%, 84% and 87.18%. The positive rate, sensitivity and negative predictive value of TB-IGRA were the highest, while the specificity of TB-DNA-PCR was the highest yet with low positive rate, sensitivity and positive predictive value. </span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><b></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><b><span style="font-family:Verdana;">Conclusion</span></b></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><b><span style="font-family:Verdana;">:</span></b></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"></b></span></span></span><span><span><b><span style="font-family:""> </span></b></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">The positive rate and sensitivity of TB-IGRA were high, yet with poor specificity, so it was impossible to judge whether the cases belonged to active pulmonary tuberculosis. The combination of PPD and TB-DNA-PCR could improve the sensitivity, specificity and positive predictive value, and the diagnostic accuracy of active pulmonary tuberculosis, which showed satisfactory clinical value.展开更多
<b><span style="font-family:Verdana;">Objective:</span></b><span style="font-family:Verdana;"> To investigate the clinical diagnostic value of </span><span st...<b><span style="font-family:Verdana;">Objective:</span></b><span style="font-family:Verdana;"> To investigate the clinical diagnostic value of </span><span style="font-family:Verdana;">TB-IGRA (Tuber</span><span style="font-family:Verdana;">culosis-Interferon Gamma Release Assay), PPD (Intradermal T</span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">u</span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">b</span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">er</span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">culin Te</span></span></span><span><span><span style="font-family:;" "=""><span><span style="font-family:Verdana;">st), TB-DNA-PCR (Tuberculosis-Deoxyribonucleic-Polymerase Chain Reaction) and ADA(Adenosine Aeaminase) in tuberculous pleural effusion. </span><b></b></span><b><b><span style="font-family:Verdana;">Methods:</span></b><span></span></b><span style="font-family:Verdana;"> 60 patients with tuberculous pleural effusion discharged from our department from January 1, 2018 to December 31, 2019 were selected. Moreover, the TB-IGRA in peripheral blood, PPD test, TB-DNA-PCR and ADA in pleural effusion were detected. Subsequently, the positive rate, negative rate, sensitivity and omission diagnostic rate of</span></span><b> </b><span style="font-family:Verdana;">TB-IGRA, PPD, TB-DNA-PCR, ADA and combined</span><b> </b><span style="font-family:Verdana;">TB-IGRA were calculated. </span><b><b><span style="font-family:Verdana;">Results:</span></b><span style="font-family:Verdana;"></span></b><span style="font-family:Verdana;"> The positive rate and sensitivi</span></span><span><span style="font-family:Verdana;">ty</span><span style="font-family:Verdana;"> of</span><span> <span style="font-family:Verdana;">TB-IGRA, PPD</span><span style="font-family:Verdana;">,</span></span><span style="font-family:Verdana;">TB-DNA-PCR, and ADA were 95%, 71.67%,</span></span></span><span><span><span style="font-family:;" "=""> </span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">5% and</span></span></span><span><span><span style="font-family:;" "=""><span style="font-family:Verdana;"> 86.67% respectively. The omission diagnostic rate was 5%, 28.33%, 95% and </span><span style="font-family:Verdana;">13.33%. TB-IGRA showed the highest positive rate and sensitivity, and TB</span><span style="font-family:Verdana;">-DNA-PCR represented the highest omission diagnostic rate. The sensitivity of TB-IGRA + PPD was 98.33%, while the omission diagnostic rate was 51.67%. The sensitivity of TB-IGRA + TB-DNA-PCR was 95%, while the omission diagnostic rate was 5%. The sensitivity of TB-IGRA + ADA was 100%, while the </span><span style="font-family:Verdana;">omission diagnostic rate was 0%. In addition, the TB-IGRA + ADA had the</span><span style="font-family:Verdana;"> highest sensitivity and the lowest omission diagnostic rate. </span><span style="font-family:Verdana;"><b></b></span><b><b><span style="font-family:Verdana;">Conclusion:</span></b><span style="font-family:Verdana;"></span></b></span><b><span> </span></b><span style="font-family:Verdana;">TB-IGRA has high positive rate, high sensitivity and low omission diagnostic rate, which is superior to the traditional sputum test for tuberculosis. Notably, the combination of PPD, TB-DNA-PCR, ADA is capable of improving the diagno</span><span style="font-family:Verdana;">sis rate, and the diagnosis rate can reach 100% when combined with ADA,</span><span style="font-family:Verdana;"> which is able to provide solid diagnostic value in clinical practice.</span></span></span>展开更多
Bovine tuberculosis (TB) is a chronic debilitating disease of huge economic importance due to loss in production, morbidity and mortality, and has a potential zoonotic threat. TB is endemic in India and has a worldwid...Bovine tuberculosis (TB) is a chronic debilitating disease of huge economic importance due to loss in production, morbidity and mortality, and has a potential zoonotic threat. TB is endemic in India and has a worldwide prevalence, therefore, needing early diagnostic technique for the eradication of TB globally. Currently, compared to the eradication programme of TB in Medical sector, Veterinary sector is lagging behind though TB is one of the major zoonotic diseases prevalent in dairy animals and wildlife in India. With the “End TB” strategy by WHO in human, parallel measures for early diagnosis and culling has to be followed in case of animals for an overall successful eradication programme. The objective of this study is diagnosis of TB in cattle and buffaloes by using the cell-mediated immune response tests, i.e. Comparative Intradermal Tuberculin Test (CITT) and Interferon gamma (IFN-γ) assay, and Polymerase Chain Reaction (PCR) targeting esxB gene (CFP-10 protein) and to compare their diagnostic capabilities. This study was carried out in 202 dairy cattle and buffaloes from an organized dairy farm, where almost all of the animals appeared clinically healthy. We found that, the combined use of both CITT and IFN-γ assay lead to more accurate diagnosis of TB, although IFN-γ assay was more specific than CITT. However, esxB PCR showed almost similar sensitivity to IFN-γ assay and may be used as a fast alternative method for the diagnosis of bovine TB from blood samples.展开更多
文摘</span><b><span style="font-family:Verdana;">Purpose</span></b></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><b><span style="font-family:Verdana;">:</span></b></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"></b></span></span></span><span><span><span style="font-family:""> </span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">The purpose of this article is </span></span></span><span><span><span style="font-family:""><span style="font-family:Verdana;">to investigate the clinical value of TB-IGRA</span><span style="font-family:Verdana;"> (Tuberculosis-Interferon </span><span style="font-family:Verdana;">Gamma Release Assay), PPD (Intradermal </span><span style="font-family:Verdana;">Terbuculin Test), TB-DNA-PCR (Tuberculosis-Deoxyribonucleic-Polymerase</span><span style="font-family:Verdana;"> Chain Reaction) and TB-Ab (Tuberculosis-Antibody) in diagnosing silicosis complicated with pulmonary tuberculosis. <b></span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><b><span style="font-family:Verdana;">Methods</span></b></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><b><span style="font-family:Verdana;">:</span></b></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"></b></span></span></span><span><span><b><span style="font-family:""> </span></b></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">53 cases of suspected silicosis complicated with pulmonary tuberculosis were selected in the time span ranging from February 2017 to May 2019. TB-IGRA test, PPD test, TB-DNA-PCR and TB-Ab detection were performed. The sensitivity, specificity, positive predictive value and negative predictive value were calculated. </span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><b></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><b><span style="font-family:Verdana;">Results</span></b></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><b><span style="font-family:Verdana;">:</span></b></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"></b></span></span></span><span><span><span style="font-family:""> </span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">Silicosis and pulmonary tuberculosis were diagnosed in 11 cases, with an incidence of 20.75%. The positive rates of TB-IGRA, PPD, TB-DNA-PCR and TB-Ab were 66.04%, 30.19%, 5.67% and 26.42%, respectively. The sensitivity was 90.91%, 81.82%, 27.27% and 54.55% respectively. The specificity was 42.86%, 80.95%, 100% and 80.95% respectively. The positive predictive values were 28.57%, 50%, 100% and 42.86% respectively. The negative predictive values were 94.44%, 91.89%, 84% and 87.18%. The positive rate, sensitivity and negative predictive value of TB-IGRA were the highest, while the specificity of TB-DNA-PCR was the highest yet with low positive rate, sensitivity and positive predictive value. </span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><b></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><b><span style="font-family:Verdana;">Conclusion</span></b></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><b><span style="font-family:Verdana;">:</span></b></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"></b></span></span></span><span><span><b><span style="font-family:""> </span></b></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">The positive rate and sensitivity of TB-IGRA were high, yet with poor specificity, so it was impossible to judge whether the cases belonged to active pulmonary tuberculosis. The combination of PPD and TB-DNA-PCR could improve the sensitivity, specificity and positive predictive value, and the diagnostic accuracy of active pulmonary tuberculosis, which showed satisfactory clinical value.
文摘<b><span style="font-family:Verdana;">Objective:</span></b><span style="font-family:Verdana;"> To investigate the clinical diagnostic value of </span><span style="font-family:Verdana;">TB-IGRA (Tuber</span><span style="font-family:Verdana;">culosis-Interferon Gamma Release Assay), PPD (Intradermal T</span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">u</span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">b</span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">er</span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">culin Te</span></span></span><span><span><span style="font-family:;" "=""><span><span style="font-family:Verdana;">st), TB-DNA-PCR (Tuberculosis-Deoxyribonucleic-Polymerase Chain Reaction) and ADA(Adenosine Aeaminase) in tuberculous pleural effusion. </span><b></b></span><b><b><span style="font-family:Verdana;">Methods:</span></b><span></span></b><span style="font-family:Verdana;"> 60 patients with tuberculous pleural effusion discharged from our department from January 1, 2018 to December 31, 2019 were selected. Moreover, the TB-IGRA in peripheral blood, PPD test, TB-DNA-PCR and ADA in pleural effusion were detected. Subsequently, the positive rate, negative rate, sensitivity and omission diagnostic rate of</span></span><b> </b><span style="font-family:Verdana;">TB-IGRA, PPD, TB-DNA-PCR, ADA and combined</span><b> </b><span style="font-family:Verdana;">TB-IGRA were calculated. </span><b><b><span style="font-family:Verdana;">Results:</span></b><span style="font-family:Verdana;"></span></b><span style="font-family:Verdana;"> The positive rate and sensitivi</span></span><span><span style="font-family:Verdana;">ty</span><span style="font-family:Verdana;"> of</span><span> <span style="font-family:Verdana;">TB-IGRA, PPD</span><span style="font-family:Verdana;">,</span></span><span style="font-family:Verdana;">TB-DNA-PCR, and ADA were 95%, 71.67%,</span></span></span><span><span><span style="font-family:;" "=""> </span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">5% and</span></span></span><span><span><span style="font-family:;" "=""><span style="font-family:Verdana;"> 86.67% respectively. The omission diagnostic rate was 5%, 28.33%, 95% and </span><span style="font-family:Verdana;">13.33%. TB-IGRA showed the highest positive rate and sensitivity, and TB</span><span style="font-family:Verdana;">-DNA-PCR represented the highest omission diagnostic rate. The sensitivity of TB-IGRA + PPD was 98.33%, while the omission diagnostic rate was 51.67%. The sensitivity of TB-IGRA + TB-DNA-PCR was 95%, while the omission diagnostic rate was 5%. The sensitivity of TB-IGRA + ADA was 100%, while the </span><span style="font-family:Verdana;">omission diagnostic rate was 0%. In addition, the TB-IGRA + ADA had the</span><span style="font-family:Verdana;"> highest sensitivity and the lowest omission diagnostic rate. </span><span style="font-family:Verdana;"><b></b></span><b><b><span style="font-family:Verdana;">Conclusion:</span></b><span style="font-family:Verdana;"></span></b></span><b><span> </span></b><span style="font-family:Verdana;">TB-IGRA has high positive rate, high sensitivity and low omission diagnostic rate, which is superior to the traditional sputum test for tuberculosis. Notably, the combination of PPD, TB-DNA-PCR, ADA is capable of improving the diagno</span><span style="font-family:Verdana;">sis rate, and the diagnosis rate can reach 100% when combined with ADA,</span><span style="font-family:Verdana;"> which is able to provide solid diagnostic value in clinical practice.</span></span></span>
文摘目的探讨结核感染T淋巴细胞酶联免疫斑点试验(tuberculosis T lymphocytes enzyme-linked immune SPOT test,T-SPOT.TB)在肺结核早期诊断中的应用价值。方法采用T-SPOT.TB,荧光定量PCR(fluorescence quantitative PCR,RQ-PCR)、结核蛋白芯片(TB-Ab protein chip)及结核菌素试验(purified protein derivative,PPD)检测189例疑似肺结核患者是否有结核菌感染。结果 T-SPOT,PCR,TB-AB和PPD方法的敏感度分别为91.54%(119/130),73.85%(96/130),63.08%(82/130)及57.69%(75/130),特异度分别为89.83%(53/59),86.44%(51/59),67.79%(40/59)及66.10%(39/59);T-SPOT.TB方法敏感度均高于荧光定量PCR法等三种方法(x^2=14.216~41.573,均P<0.05),TSPOT.TB方法特异度均高于PPD试验及结核蛋白芯片方法(x^2=8.577~9.669,P<0.05);T-SPOT.TB,荧光定量PCR,TB-Ab及PPD阳性预测值分别为95.2%(119/125),92.3%(96/104),81.2%(82/101)和78.9%(75/95).而阴性预测值分别为82.8%(53/64),60%(51/85),45.5%(40/88)和41.5%(39/94);四种检测方法的假阳性率(误诊率)分别为10.2%(6/59),13.6%(8/59),32.2%(19/59)和33.9%(20/59),而假阴性率(漏诊率)分别为8.5%(11/130),26.2%(34/130),36.9%(48/130)和42.3%(55/130);四种检测方法的阴性似然比分别为0.11,0.16,0.48和0.51,而阳性似然比分别为9.0,5.4,2.0和1.7;四种检测方法的诊断符合率分别为91.0%(172/189),77.8%(147/189),64.6%(122/189)和60.3%(114/189);T-SPOT.TB,荧光定量PCR,TB-Ab及PPD的约登指数分别为0.81,0.60,0.31和0.24。结论在实验室检测早期结核菌感染的方法中T-SPOT.TB检测法是较敏感且特异度较高的方法,对不同阶段肺结核诊断更具临床应用价值。
文摘Bovine tuberculosis (TB) is a chronic debilitating disease of huge economic importance due to loss in production, morbidity and mortality, and has a potential zoonotic threat. TB is endemic in India and has a worldwide prevalence, therefore, needing early diagnostic technique for the eradication of TB globally. Currently, compared to the eradication programme of TB in Medical sector, Veterinary sector is lagging behind though TB is one of the major zoonotic diseases prevalent in dairy animals and wildlife in India. With the “End TB” strategy by WHO in human, parallel measures for early diagnosis and culling has to be followed in case of animals for an overall successful eradication programme. The objective of this study is diagnosis of TB in cattle and buffaloes by using the cell-mediated immune response tests, i.e. Comparative Intradermal Tuberculin Test (CITT) and Interferon gamma (IFN-γ) assay, and Polymerase Chain Reaction (PCR) targeting esxB gene (CFP-10 protein) and to compare their diagnostic capabilities. This study was carried out in 202 dairy cattle and buffaloes from an organized dairy farm, where almost all of the animals appeared clinically healthy. We found that, the combined use of both CITT and IFN-γ assay lead to more accurate diagnosis of TB, although IFN-γ assay was more specific than CITT. However, esxB PCR showed almost similar sensitivity to IFN-γ assay and may be used as a fast alternative method for the diagnosis of bovine TB from blood samples.